Search research articles
Contact Us
Filters
Showing results (121-130 of 125) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 125 results.
Haematologica
|
December 30, 2021
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, et al.
The Lancet. Oncology
|
January 20, 2019
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
John M M Raemaekers, Marc P E André, Massimo Federico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M Kurtz, Florian Scherer, Michael C Jin, et al.
Leukemia & Lymphoma
|
March 8, 2017
Report of the 6th International Workshop on PET in lymphoma
Cristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 125) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 125 results.
Haematologica
|
December 30, 2021
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, et al.
The Lancet. Oncology
|
January 20, 2019
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
John M M Raemaekers, Marc P E André, Massimo Federico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M Kurtz, Florian Scherer, Michael C Jin, et al.
Leukemia & Lymphoma
|
March 8, 2017
Report of the 6th International Workshop on PET in lymphoma
Cristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, et al.
Page
of 13